Cited 0 time in
Regulation of gastric carcinoma development in gastric adenoma/dysplasia by crebzf inhibition via miRNA-421
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Yu Jin | - |
| dc.contributor.author | Kim, Won Shik | - |
| dc.contributor.author | Kim, Sang Woo | - |
| dc.contributor.author | Jung, Woon Yong | - |
| dc.date.accessioned | 2021-09-27T06:17:07Z | - |
| dc.date.available | 2021-09-27T06:17:07Z | - |
| dc.date.created | 2021-09-24 | - |
| dc.date.issued | 2020-02-01 | - |
| dc.identifier.issn | 0732-183X | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/133069 | - |
| dc.language | 영어 | - |
| dc.language.iso | en | - |
| dc.publisher | AMER SOC CLINICAL ONCOLOGY | - |
| dc.title | Regulation of gastric carcinoma development in gastric adenoma/dysplasia by crebzf inhibition via miRNA-421 | - |
| dc.type | Conference | - |
| dc.contributor.affiliatedAuthor | Jung, Woon Yong | - |
| dc.identifier.wosid | 000530922700393 | - |
| dc.identifier.bibliographicCitation | Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology | - |
| dc.relation.isPartOf | Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology | - |
| dc.relation.isPartOf | JOURNAL OF CLINICAL ONCOLOGY | - |
| dc.citation.title | Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology | - |
| dc.citation.conferencePlace | US | - |
| dc.citation.conferencePlace | San Francisco, CA | - |
| dc.citation.conferenceDate | 2020-01-23 | - |
| dc.type.rims | CONF | - |
| dc.description.journalClass | 1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
